Article info

Letter
Prescription opioid use in multiple sclerosis

Authors

  • Ruth Ann Marrie Department of Internal Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada Department of Community Health Sciences, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • John D Fisk Psychiatry, Medicine, Psychology, and Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada PubMed articlesGoogle scholar articles
  • Randy Walld Manitoba Centre for Health Policy, CAN, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • James M Bolton Department of Psychiatry, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Jitender Sareen Department of Psychiatry, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Scott B Patten Community Health Sciences, University of Calgary, Calgary, Alberta, Canada PubMed articlesGoogle scholar articles
  • Alexander Singer Department of Family Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Lisa M Lix Department of Community Health Sciences, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Carol A Hitchon Department of Internal Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Renée El-Gabalawy Department of Clinical Health Psychology, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada Department of Anesthesiology, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Alan Katz Department of Community Health Sciences, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada Manitoba Centre for Health Policy, CAN, Winnipeg, Manitoba, Canada Department of Family Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • James J Marriott Department of Internal Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Charles N Bernstein Department of Internal Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ruth Ann Marrie, Internal Medicine, University of Manitoba College of Medicine, Winnipeg, MB R3A 1R9, Canada; rmarrie{at}hsc.mb.ca
View Full Text

Citation

Marrie RA, Fisk JD, Walld R, et al
Prescription opioid use in multiple sclerosis

Publication history

  • Received June 28, 2022
  • Accepted August 17, 2022
  • First published August 26, 2022.
Online issue publication 
January 11, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.